Update: UK Biotech Scores £5M Series A to Boost Next-Generation Cancer Antibodies
Update (30/11/2018): IGEM Therapeutics has increased the total raised in Series A to £5M (€5.6M)…
Update (30/11/2018): IGEM Therapeutics has increased the total raised in Series A to £5M (€5.6M)…
A new study concludes the majority of cancer drugs approved by the EMA between 2009…
Researchers from the UK have described a new treatment for cavities that could get rid…
Biodesigner Amy Congdon envisions a future where biotechnology is essential in all aspects of our…
The needle-free revolution for diabetes is coming! We interviewed Panos Kosmas, co-founder of MediWise, to get…
Biotech is one of the main forces driving the development of effective therapies to treat neurological and…
Researchers at King's College London have found a new link between gut microbiome diversity (or,…
HIV has completely disappeared from the blood of a patient in clinical trials. The new HIV treatment that…
Just when we thought it couldn't become any more intense, the field of immuno-oncology is…
Patients suffering from a rare autoimmune disorder could actually be the key for a new…
Researchers from King’s College London have succeeded in developing a blood test that can help choose…
Gritstone Pharmaceuticals is a US start-up which will focus on R&D of its new CAR-T…